3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
5
Phase 2
5
Phase 4
2
Phase 1/2
2
Phase 1
2
Phase 3
1
Status
Completed
12
Recruiting
5
Unknown
4
Terminated
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Breast
1
Conditions
Neoplasms
282
Carcinoma, Non-Small-Cell Lung
253
Leukemia, Myeloid, Acute
190
Breast Neoplasms
153
Melanoma
151
Neoplasm Metastasis
148
Multiple Myeloma
127
Recurrence
123
Colorectal Neoplasms
119
Lymphoma, Non-Hodgkin
114
Lymphoma
113
Leukemia, Lymphocytic, Chronic, B-Cell
108
Pancreatic Neoplasms
99
Ovarian Neoplasms
99
Precursor Cell Lymphoblastic Leukemia-Lymphoma
91
Leukemia
86
Prostatic Neoplasms
83
Lung Neoplasms
82
Lymphoma, Large B-Cell, Diffuse
77
Squamous Cell Carcinoma of Head and Neck
76
Glioblastoma
73
Carcinoma, Renal Cell
72
Myelodysplastic Syndromes
68
Lymphoma, Follicular
65
Brain Neoplasms
60
Lymphoma, Mantle-Cell
55
Sarcoma
53
Stomach Neoplasms
52
Head and Neck Neoplasms
52
Triple Negative Breast Neoplasms
51
Interventions
lipoplatin
1
Verteporfin
1
SPI-77, liposomal
1
Photochemotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Terminated
×
Pleural Effusion, Malignant
×
Clear all
NCT02702700
2019-03-20
PDT-lipo
Centre Hospitalier Universitaire Vaudois
Phase 1
Terminated
1 enrolled
NCT02250118
2017-11-06
BEVAP
Institut Curie
Phase 1
Terminated
1 enrolled